Search

Your search keyword '"Ching-Wei D Tzeng"' showing total 324 results

Search Constraints

Start Over You searched for: Author "Ching-Wei D Tzeng" Remove constraint Author: "Ching-Wei D Tzeng"
324 results on '"Ching-Wei D Tzeng"'

Search Results

1. Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

2. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients

3. Risk-stratified posthepatectomy pathways based upon the Kawaguchi–Gayet complexity classification and impact on length of stay

4. NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience

5. 3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma

6. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients

8. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors

9. Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy

10. Novel EUS-guided brachytherapy treatment of pancreatic cancer with phosphorus-32 microparticles: first United States experience

11. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis

12. Individual components of post-hepatectomy care pathways have differential impacts on length of stay

13. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma

14. Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

16. Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

17. Association of Patient Controlled Analgesia and Total Inpatient Opioid Use After Pancreatectomy

20. Lymphadenectomy and margin‐negative resection for biliary tract cancer surgery in the United States—Differential technical performance by approach

23. Effects of a Pragmatic Home-based Exercise Program Concurrent with Neoadjuvant Therapy on Physical Function of Patients with Pancreatic Cancer

24. Figure SF1 from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

25. Table S4 from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

26. Data from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

27. Data from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

28. Supplementary Table from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

29. Supplementary Figure from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

30. Data from Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases

31. Supplementary Figure 3 from Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases

34. Supplementary Figure 4 from Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases

35. Supplementary Data from Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases

41. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases

42. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study

44. Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer

45. Association of Medicaid Expansion with Pancreatic Cancer Treatment and Outcomes: Evidence from the National Cancer Database

46. Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy

47. Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients

48. Single cell sequencing reveals trajectory of tumor-infiltrating lymphocyte states in pancreatic cancer

50. Developing a Value Framework: Utilizing Administrative Data to Assess an Enhanced Care Initiative

Catalog

Books, media, physical & digital resources